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ABSTRACT
Chronic kidney disease (CKD) is a condition defined by the progressive loss of renal function and damag-
ing, in the course of months or years. Its rising incidence on a global scale compels doctors of dental medi-
cine to be aware of the oral manifestations and symptoms affecting the soft and hard dental tissues, which 
are related to the underlying condition or its treatment. The objective of this review is to look into the oral 
changes affecting some of the patients with terminal kidney failure receiving chronic dialysis treatment. 
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INTRODUCTION
Chronic kidney disease (CKD) is among chron-
ic diseases most frequently leading to long-term and 
significant deterioration of the quality of life. It is a 
clinical and laboratory syndrome occurring as a re-
sult of the progressive loss of renal function and 
damaging over months and years. Typically, the glo-
merular filtration rate is reduced and the serum cre-
atinine and urea levels are increased. The most com-
mon causes contributing to CKD are primarily: arte-
rial hypertension, diabetes mellitus, chronic glomer-
ulonephritis, chronic interstitial nephritis, arterial 
hypertension, and autoimmune conditions (1,2,3).
According to data for 2012, about 8 % of the 
human population (over 50 mil. people) are affect-
ed by CKD with an upward trend in almost all coun-
tries (4,5,6). The incidence of the disease in Bulgar-
ia is nearly 10% (about 700,000 - 750,000 people). In 
2015, the total number of patients treated in dialy-
sis centres across the country was 4,000 people. Of 
those, there are currently over 3,500 people receiving 
substitutive dialysis treatment. Forecasts show their 
numbers will continue to rise due to the constant rise 
in patients with Type 2 diabetes mellitus and hyper-
tension (7,8,9).
Patients with CKD are at high risk of develop-
ing oral complications related to their underlying 
condition or as a result of its treatment (10). A num-
ber of studies have found that the length of dialysis 
treatment influences the development of oral chang-
es (11,12,13). In up to 90% of such patients, manifes-
tations and symptoms affecting the soft and hard 
dental tissues may occur, forcing dental treatment 
to adapt to the underlying condition and the main 
general manifestations of the disease, which requires 
dental specialists to have an in-depth knowledge.
The possible oral and facial issues in patients 
with CKD are:
 gingival hyperplasia
 generalized gingivitis catarrhalis
 inflammatory changes in oral mucosa
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 paleness of oral mucosa as a result of anaemic 
syndrome 
 xerostomia 
 impeded/altered taste sensation
 uremic fetor
 uremic glossitis 
 uremic stomatitis
 individual tooth mobility 
 heavy and irregular calculus builds up 
 delayed tooth eruption
 enamel hypoplasia 
 narrowing of the dental pulp chamber
 diminished prevalence of caries 
 bone changes
Halitosis and Uremic Fetor
Halitosis may be a result of poor oral health, 
xerostomia or oral microorganisms metabolising 
urea (14). Uremic fetor is a well-recognised symp-
tom of CKD patients. The reduced kidney function 
leads to higher levels of urea in the blood and the sa-
liva, where it transforms to ammonia. The urea re-
leased in the mouth cavity becomes hydrolysed lead-
ing to the secretion of ammonia that is responsible 
for the bitter taste in the mouth (uremic fetor -foetor 
uraemicus) and the more alkaline the pH of the sa-
liva. This typical uremic fetor is reported by 1/3 (one 
third) of the patients in dialysis treatment (15).
Xerostomia – results from the limited liquid in-
take, side effects of drug therapy and the bad habit 
of breathing through the mouth. Continuous xero-
stomia is a predisposition to tooth caries and gingi-
val inflammation, and later difficulties in speech and 
the act of chewing, loss of taste sensations, oral infec-
tions such as candidiasis and acute suppurative sialo-
adenitis (16,17).
Altered (Impeded) Taste Sensation – caused 
by metabolic disorders, a systematic use of drugs, 
lowered number of taste buds and changes in the 
speed of saliva secretion (18).
Uremic Stomatitis is an oral complication of 
yet undefined aetiology that is usually seen in pa-
tients with end stage kidney diseases. It can mani-
fest as white, red or grey lesions on the oral mucosa. 
It is thought that it may be due to the chemical trau-
ma of the oral mucosa from the heightened levels of 
nitrogen compounds (16). The diagnosis is made by a 
combination of the typical clinical presentation with 
the histology result – inflammatory infiltrate with 
hyperplastic epithelia, which normally presents with 
abnormal keratinisation. (19,20).
Enamel Hypoplasia is a common oral mani-
festation in patients with CKD. It is due to hypocal-
caemia, poor vitamin D3 metabolism, metabolic ac-
idosis, frequent intake of drugs affecting the amelo-
blast function. It manifests in 31% of primary (baby) 
teeth and affecting between 12% and 39% of per-
manent (adult) teeth. The clinical picture is linked 
to the reduced quantity of enamel as well as enam-
el defects manifesting in the shape of fissures, lines, 
dots and tooth discoloration in the yellowish - brown 
range. An altered teeth morphology is also observed 
as manifested in irregular incisive edges and tuber-
cles (21). 
Tooth Anomalies
In some CKD patients, narrowing of the den-
tal pulp chamber is observed. It is assumed that this 
is due to the changes in calcium and phosphorus me-
tabolism in patients with systemic kidney disease 
(15,22). The exact reason for this dental alteration is 
unknown. Kidney transplant patients have a consid-
erably narrower dental pulp chamber than patients 
on substitution treatment (16).
Tooth Mobility – possibly a result from kid-
ney osteodystrophy, often seen in patients with kid-
ney failure and as a result of secondary hyperpara-
thyroidism (21,23).
Gingival Hyperplasia – secondary to drug 
treatment, as a result of cyclosporines and/or calci-
um antagonists and is one of the most typical and 
common manifestations of kidney disease. It is a 
consequence of hyperplasia of the connective tissue 
and epithelia. The histology is typical – packed par-
allel collagen fibres with an increased number of fi-
broblasts and newly formed blood vessels. Acan-
thosis of the epithelium and epithelial in-growth in 
the connective tissue spreading deep within, may be 
observed.
Gingival hyperplasia can be seen around the 
front teeth (localised form) mainly, but can also be 
observed around all teeth (generalised form). Nor-
mally, the process begins from the interdental papil-
la, with the hyperplasia later expanding to the gingi-
va. This oral manifestation is present in 6 to 85% of 
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patients on cyclosporine. Clinical presentation could 
become obvious as early as the first three months 
from the onset of the cyclosporine therapy. Children 
and youths are more susceptible to drug-induced 
gingival hyperplasia than adults (16). Nifedipine-in-
duced hyperplasia is present in 10-83% of treated pa-
tients. Poor oral hygiene and tartar can also be a pre-
disposition to gingival hyperplasia.
Earlier studies suggest that the oral hygiene 
of patients on haemodialysis is poorer than that of 
the general public as a whole (21). One probable rea-
son is the chronic nature of the disease. Such pa-
tients are prone to overlooking preventive measures 
linked to other aspects of health (14). The increased 
deposit of tartar compared to healthy people is pos-
sibly connected to the high levels of urea and phos-
phates in the saliva, as well as the larger quantities of 
calcium carbonate they take (14). Poor oral hygiene 
and plaque development are risk factors for the on-
set of periodontal disease, which in turn is a potential 
cause for a prolonged systemic inflammation in this 
group of patients (14). Other authors have document-
ed that the higher levels of urea in the saliva have an 
antibacterial effect, and that in that group of patients 
the incidents of dental caries are lower (24).
To summarise, it is assumed, that in patients 
with CKD, the compromised oral status and the in-
creased accumulation of tartar are contributing fac-
tors to oral diseases (14).
Oral Mucosa Lesions – often occur secondary 
to drug therapy (for example diuretics beta-blockers, 
etc.) For instance, hairy leukoplakia may result from 
immunosuppression (16).
Some of the oral lesions in the spectrum, typical 
for CKD patients on HD are:
 oral erosions and ulcers
 oral lichen planus
 histopathology similar to Epstein - Barr virus-
associated lesions – hairy leukoplakia
 white and erythematous patches
 uremic stomatitis
 geographic tongue and others
Malignant Oral Lesions
Kaposi’s sarcoma has been described in kid-
ney transplant patients. There is data for the develop-
ment squamous cell carcinoma in areas of cyclospo-
rine-induced gingival hyperplasia. Continuous im-
munosuppressive treatment after kidney transplan-
tation may predispose to the development of Kapo-
si’s sarcoma.
Infections of the Oral Mucosa (Infections of the 
Mouth Cavity)
CKD patients on substitutive treatment, due 
to being immunosuppressed, can develop angular 
cheilitis, gingivitis or chronic atrophic candidiasis 
(16). Nearly 100 % of those have a periodontal dis-
ease. Causes are not completely clear but it is sug-
gested that systemic treatment with anticoagulants 
in patients on HD, may be a predisposing factor for 
spontaneous bleeding from the gums that facilitates 
bacterial colonisation in the oral cavity (24). The sec-
ondary hyperparathyroidism is another possible rea-
son for the periodontal diseases in patients with ter-
minal kidney failure (24). Periodontitis is a potential 
source of bacteraemia, particularly in immuno-com-
promised patients (24,17). 
Bone Lesions (“Bone Disease”) – varying from 
conditions affecting mineralisation to conditions 
significantly increasing bone metabolism (hyper-
parathyroidism). Bone changes in the maxillofacial 
area in chronic kidney failure are secondary to renal 
osteodystrophy. It causes reduced generation of ac-
tive vitamin D, leading in turn to lower serum levels 
of calcium and higher levels of parathormone (PTH) 
(25).
Renal osteodystrophy presents with a num-
ber of X-ray imaging changes in the upper and low-
er jaws. There is data for reduction or loss of cortical 
bone of the mandibular angle and around the max-
illary sinuses (obscuration of the X-ray contrast lines 
depicting the outlines of the maxillary sinus), fora-
men mentale, the mandibular canal.
Bibliographical data (16) shows that hyperpara-
thyroidism-based bone orofacial characteristics of 
renal osteodystrophy are:
 bone demineralisation
 reduction of trabeculae spaces
 thinning of cortical bone
 matt glass phenomenon in bone (trabeculae ar-
rangement with matt-glass-like appearance)
 bone lesions with reduced X-ray density
 metastatic soft-tissue calcifications
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 osteolytic lesions
 jaw fracture (spontaneous or during dental 
treatment)
 abnormal post extraction bone modelling
In some cases, in patients on prolonged haemo-
dialysis significant expansion of the jaw bones’ size 
may be observed (macrognathia), leading to facial 
deformities (24,26,27).
Bone demineralisation may lead to fast bone 
destruction.
Orofacial characteristics of the renal osteodys-
trophy affecting teeth and the periodontium are: 
 enamel hypoplasia
 lamina dura loss (full or partial loss of the lam-
ina dura) 
 expansion of the periodontal ligament
 severe periodontal destruction
 tooth mobility
 pulp calcification (pulp changes)
 narrowing of the dental pulp chamber
CONCLUSION
There is a proven high incidence of oral pathol-
ogy in patients with end stage CKD receiving chron-
ic dialysis treatment. This necessitates a comprehen-
sive discussion of the problem and requires and in-
terdisciplinary team of a general practitioner, a spe-
cialist nephrologist and a dental physician. Dental 
medical doctors must be able to expect, identify and 
treat adequately any changes occurring in the maxil-
la-facial area in this group of patients. 
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